Integra LifeSciences Holdings Corporation (IART) on Thursday reported a loss of $1.70 million, or $0.02 per share for the fourth quarter, compared with a profit of $19.44 million, or $0.25 per share, in the same quarter last year.
Excluding one-time items, the company posted earnings of $63.7 million, or $0.83 per share.
Operating income fell to $23.04 million from $35.63 million a year earlier.
Total revenue edged down 1.7% to $434.93 million from $442.65 million in the prior-year quarter.
Integra LifeSciences expects full-year 2026 revenue of $1.662 billion to $1.702 billion, representing a growth of 1.6% to 4.1%. Adjusted earnings per share are projected at $2.30 to $2.40.
For the first quarter, the company forecasts revenue of $375 million to $390 million, implying a decline of 2% to growth of 1.9%. Adjusted earnings per share are expected in the range of $0.37 to $0.45.
Integra LifeSciences shares closed at $11.59 on Wednesday, up 0.52%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.